{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:34Z","timestamp":1761519094266,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1007\/bf03343826","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T18:34:53Z","timestamp":1397154893000},"page":"131-134","source":"Crossref","is-referenced-by-count":10,"title":["Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?"],"prefix":"10.1007","volume":"24","author":[{"given":"D.","family":"Sudhaker Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343826_CR1","first-page":"26","volume-title":"The Wall Street Journal","author":"JE Bishop","year":"1980","unstructured":"Bishop J.E. Soaring medical costs and the Mayo \u201cepidemic\u201d. The Wall Street Journal 1980, 26."},{"key":"BF03343826_CR2","first-page":"194","volume":"33","author":"DS Rao","year":"1985","unstructured":"Rao D.S. Primary hyperparathyroidism: changing patterns in presentation and treatment decisions in the Eighties. Henry Ford Hospital Med. J. 1985, 33: 194\u2013197.","journal-title":"Henry Ford Hospital Med. J."},{"key":"BF03343826_CR3","first-page":"723","volume-title":"Vitamin D: Chemistry, biology, and clinical applications of the steroid hormone","author":"DS Rao","year":"1997","unstructured":"Rao D.S., Phillips E., Honasoge M., Mithal A., Mishra S.D., Singh A.K., Han Z.-H., Parikh N., Lee M., Talpos G.B. Role of vitamin D nutrition in primary hyperpa-rathyroidism: effect on parathyroid gland mass and on bone. In: Norman A.W., Boullion R., Thomasset M. (Eds.), Vitamin D: Chemistry, biology, and clinical applications of the steroid hormone. University of California-Riverside, Riverside, 1997, pp. 723\u2013724."},{"key":"BF03343826_CR4","first-page":"1054","volume":"85","author":"DS Rao","year":"2000","unstructured":"Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., Talpos G.B., Parfitt A.M. Effect of vitamin D nutrition on parathyroid ade noma weight: pathogenetic and clinical implica tions. J. Clin. Endocrinol. Metab. 2000, 85: 1054\u20131058.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343826_CR5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03343810","volume":"23","author":"J Rastad","year":"2001","unstructured":"Rastad J. Parathyroidectomy for asymptomatic primary hyper-parathyroidism (PHPT): Is it worth the risk? J. Endocrinol. Invest. 2001, 23: 56\u201361.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343826_CR6","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1002\/jbmr.5650061421","volume":"6","author":"AM Parfitt","year":"1991","unstructured":"Parfitt A.M., Rao D.S., Kleerekoper M. Asymptomatic primary hyperparathyroidism dis covered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J. Bone Miner. Res. 1991, 6: S97\u2013S101.","journal-title":"J. Bone Miner. Res."},{"key":"BF03343826_CR7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","volume":"67","author":"DS Rao","year":"1988","unstructured":"Rao D.S., Wilson R.J., Kleerekoper M., Parfitt A.M. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J. Clin. Endocrinol. Metab. 1988, 67: 1294\u20131298.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343826_CR8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","volume":"109","author":"RJ Wilson","year":"1988","unstructured":"Wilson R.J., Rao D.S., Ellis B., Kleerekoper M., Parfitt A.M. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann. Intern. Med. 1988, 109: 959\u2013962.","journal-title":"Ann. Intern. Med."},{"key":"BF03343826_CR9","doi-asserted-by":"crossref","unstructured":"Proceedings of the NIH consensus development con ference on diagnosis and management of asymp tomatic primary hyperparathyroidism. J. Bone Miner. Res. 1991, 6: S9\u2013S13.","DOI":"10.1002\/jbmr.5650061406"},{"key":"BF03343826_CR10","first-page":"205","volume":"2","author":"M Kleerekoper","year":"1991","unstructured":"Kleerekoper M., Rao D.S., Talpos G.B., Bone H.G. Management of asymptomatic primary hyperpara- thyroidism. Adv. Endocrinol. Metab. 1991, 2: 205\u2013220.","journal-title":"Adv. Endocrinol. Metab."},{"key":"BF03343826_CR11","first-page":"723","volume":"80","author":"SJ Silverberg","year":"1995","unstructured":"Silverberg S.J., Gartenberg F., Jacobs T.P., Shane E., Siris E., Staron R.B., Bilezikian J.P. Longitudinal measurements of bone density and biochemical indices in untreated primary hyper- parathyroidism. J. Clin. Endocrinol. Metab. 1995, 80: 723\u2013728.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343826_CR12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyper-parathyroidism with or without parathyroid surgery. N. Engl. J. Med. 1999, 341: 1249\u20131255.","journal-title":"N. Engl. J. Med."},{"key":"BF03343826_CR13","first-page":"4007","volume":"81","author":"SJ Silverberg","year":"1996","unstructured":"Silverberg S.J., Locker F.G., Bilezikian J.P. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1996, 81: 4007\u20134012.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343826_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(87)91906-4","volume":"1","author":"M Palmer","year":"1987","unstructured":"Palmer M., Bergstrom R., Akerstrom G., Adami H., Jakobsson S., Ljunghall S. Survival and renal function in untreated hypercal-cemia: population-based cohort study with 14 years of follow-up. Lancet 1987, 1: 59\u201362.","journal-title":"Lancet"},{"key":"BF03343826_CR15","first-page":"241","volume":"54","author":"S Posen","year":"1985","unstructured":"Posen S., Clifton-Bligh P., Reeve T.S., Wagstaffe C., Wilkinson M. Is parathyroidectomy of benefit in primary hyper-parathyroidism? Q. J. Med. 1985, 54: 241\u2013251.","journal-title":"Q. J. Med."},{"key":"BF03343826_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-83-3-365","volume":"83","author":"RT Dauphine","year":"1975","unstructured":"Dauphine R.T., Riggs B.L., Scholz D.A. Back pain and vertebral crush fractures: an unem-phasized mode of presentation for primary hyper-parathyroidism. Ann. Intern. Med. 1975, 83: 365\u2013367.","journal-title":"Ann. Intern. Med."},{"key":"BF03343826_CR17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/17453678909149275","volume":"60","author":"K Larsson","year":"1989","unstructured":"Larsson K., Lindh E., Persson I., Ljunghall S. Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta. Orthop. Scand. 1989, 60: 268\u2013270.","journal-title":"Acta. Orthop. Scand."},{"key":"BF03343826_CR18","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.1992.00400230081014","volume":"152","author":"LJI Melton","year":"1992","unstructured":"Melton L.J.I., Atkinson E.J., O\u2019Fallon M., Heath H.I. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch. Intern. Med. 1992, 152: 2269\u20132273.","journal-title":"Arch. Intern. Med."},{"key":"BF03343826_CR19","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S., Melton L.J.I., Wermers R.A., Crowson C.S., O\u2019Fallon M., Riggs B.L. Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner. Res. 1999, 14: 1700\u20131707.","journal-title":"J. Bone Miner. Res."},{"key":"BF03343826_CR20","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1002\/jbmr.5650090319","volume":"9","author":"DS Rao","year":"1994","unstructured":"Rao D.S., Phillips E., Jacobsen G., Divine G. Natural history of untreated mild primary hyperpara-thyroidism (PHPT): First five year results of a prospective clinical study. J. Bone Miner. Res. 1994, 9: S423.","journal-title":"J. Bone Miner. Res."},{"key":"BF03343826_CR21","first-page":"S164","volume":"15","author":"DS Rao","year":"2000","unstructured":"Rao D.S., Phillips E.R., Divine G.W., Talpos G.B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic prima ry hyperparathyroidsm: Final report. J. Bone Miner. Res. 2000, 15: S164.","journal-title":"J. Bone Miner. Res."},{"key":"BF03343826_CR22","first-page":"1815","volume":"85","author":"G Barletta","year":"2000","unstructured":"Barletta G., De Feo M.L., Del Bene R., Lazzeri C., Vecchiarino S., La Villa G., Brandi M.L., Franchi F. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2000, 85: 1815\u20131821.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343826_CR23","first-page":"S380","volume":"23","author":"DS Rao","year":"1998","unstructured":"Rao D.S., Alam M., Maciejko J.J., Phillips E., Divine G.W., Talpos G.B. Cardiac function and lipid profile in mild asymptomatic primary hyperparathyroidism: effect in a randomized trial of parathyroidectomy. Bone 1998, 23: S380.","journal-title":"Bone"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343826\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T10:07:33Z","timestamp":1746180453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["BF03343826"],"URL":"https:\/\/doi.org\/10.1007\/bf03343826","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"type":"print","value":"0391-4097"},{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}